![Patrick Fabbio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Fabbio
Director of Finance/CFO at
PROTARA THERAPEUTICS, INC.
Net worth: 287 955 $ as of 29/06/2026
Profile
Patrick Fabbio currently works at BeyondSpring, Inc., as Independent Director from 2018 and Protara Therapeutics, Inc., as Chief Financial Officer from 2023.
Mr. Fabbio also formerly worked at NPS Pharmaceuticals, Inc., as Vice President-Finance from 2012 to 2015, Biomatrix, Inc., as Controller, Progenics Pharmaceuticals, Inc., as Chief Financial Officer, Secretary & Senior VP, Ikano Therapeutics, Inc., as Chief Financial Officer from 2009 to 2011, Coopers & Lybrand (London), as Auditor, Catalent Pharma Solutions, Inc., as Vice President-Finance, Innovation & Growth, electroCore, Inc., as Chief Financial Officer, WindMIL Therapeutics, Inc., as Chief Financial Officer from 2020 to 2021, and Rafael Holdings, Inc., as Chief Financial & Accounting Officer in 2023.
Mr. Fabbio received his undergraduate degree from Pace University and Masters Business Admin degree from The Leonard N Stern School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 25/01/2026 | 64,115 ( 0.11% ) | 244 919 $ | 29/06/2026 | |
BEYONDSPRING INC. 0.06% | 31/03/2026 | 24,592 ( 0.06% ) | 43 036 $ | 29/06/2026 |
Patrick Fabbio active positions
| Companies | Position | Start |
|---|---|---|
| BEYONDSPRING INC. | Director/Board Member | 01/01/2018 |
| PROTARA THERAPEUTICS, INC. | Director of Finance/CFO | 29/01/2023 |
Former positions of Patrick Fabbio
| Companies | Position | End |
|---|---|---|
| RAFAEL HOLDINGS, INC. | President | 31/12/2022 |
WindMIL Therapeutics, Inc.
 WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Director of Finance/CFO | 31/08/2021 |
| PROGENICS PHARMACEUTICALS, INC. | Director of Finance/CFO | 26/03/2020 |
| NPS PHARMACEUTICALS, INC. | Director of Finance/CFO | 30/04/2015 |
Ikano Therapeutics, Inc.
 Ikano Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director of Finance/CFO | 17/01/2011 |
Training of Patrick Fabbio
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
59
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for bone and mineral disorders | Health Technology |
Biomatrix, Inc.
 Biomatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets viscoelastic products | Health Technology |
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
Ikano Therapeutics, Inc.
Ikano Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Pace University
 Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coopers & Lybrand (London)
 Coopers & Lybrand (London) Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Health Technology |
electroCore, Inc.
 electroCore, Inc. Medical SpecialtiesHealth Technology Develops non-invasive neuromodulation therapies | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Health Technology |
BeyondSpring, Inc.
 BeyondSpring, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cancer therapies | Health Technology |
Rafael Holdings, Inc.
 Rafael Holdings, Inc. Real Estate DevelopmentFinance Operates as holding company with interest in real estate and pharmaceutical sector | Finance |
Protara Therapeutics, Inc.
 Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Patrick Fabbio
